What is toxoplasmosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Toxoplasmosis

Toxoplasmosis is a parasitic infection caused by the obligate intracellular protozoan Toxoplasma gondii that infects approximately one-third of the world's population and can cause devastating consequences for fetuses, immunocompromised patients, and occasionally immunocompetent individuals. 1

The Causative Organism

  • Toxoplasma gondii is an obligate intracellular parasite with worldwide distribution that infects any nucleated cell in any warm-blooded animal. 1
  • The parasite has a complex life cycle with cats (Felidae family) serving as the definitive hosts that shed infectious oocysts in their feces. 1
  • Humans and other animals serve as intermediate hosts and become infected incidentally through various routes. 1

Routes of Transmission

The primary routes of human infection are oral ingestion of oocysts from cat feces-contaminated soil, food, or water (accounting for approximately 78% of infections in pregnant women), and consumption of undercooked meat containing tissue cysts. 2

Additional transmission routes include:

  • Transplacental transmission from an acutely infected mother to the fetus during pregnancy or within 3 months before conception. 1
  • Organ transplantation from an infected donor. 1
  • Blood transfusion (rare). 1
  • Laboratory accidents (rare). 1
  • Reactivation in severely immunocompromised pregnant women who were previously immune. 1
  • Reinfection with a more virulent strain in previously immune individuals. 1

Clinical Manifestations

In Immunocompetent Individuals

  • 70-90% of acquired infections in children and adults are asymptomatic. 3
  • When symptomatic, cervical lymphadenopathy is the most frequent clinical finding, often accompanied by a mononucleosis-like syndrome with malaise, fever, sore throat, myalgia, and occasionally a maculopapular rash and hepatosplenomegaly. 3
  • The disease is usually benign and self-limited in immunocompetent individuals. 3

In Congenitally Infected Infants

Congenital toxoplasmosis can cause significant fetal and neonatal harm, with devastating long-term consequences. 1

  • 70-90% of infected infants are asymptomatic at birth, but the majority develop late sequelae ranging from months to years later. 4
  • Among severely affected infants, 92% develop chorioretinitis, 80% have intracranial calcifications, 68% have hydrocephalus, and 62% have all three manifestations. 1
  • Without maternal treatment, 85% of infected children develop vision impairment, 36% have recurrent eye disease, 27% have abnormal cognition, and 16% experience IQ decrease >15 points. 2
  • Late sequelae include progressive retinitis, seizures (which may develop de novo between 3-5 years of age), developmental delays, intellectual disability, and neurologic deterioration. 4

In Immunocompromised Patients

  • Toxoplasmic encephalitis should be considered in all HIV-infected patients presenting with new neurologic findings (fever, altered consciousness, seizures, focal deficits), regardless of whether symptoms are focal or diffuse. 3
  • The disease can be fatal in immunosuppressed individuals, causing disseminated disease affecting virtually any organ system. 5

Epidemiology

  • In the United States, approximately 91% of women of childbearing age are susceptible to Toxoplasma infection, with seroprevalence declining from 15% in 1988-1994 to 9% in 2009-2010. 1
  • The incidence of congenital toxoplasmosis is estimated at 1 per 1,000-12,000 live births in the United States. 3
  • Approximately half of infected individuals have no conventional risk factors (no exposure to cat litter or raw meat) and report no symptoms at the time of primary infection. 1, 2

Important Clinical Pitfalls

  • Do not assume a normal newborn screen or asymptomatic presentation at birth excludes congenital toxoplasmosis—most affected infants develop problems months to years later. 4
  • Do not rely on selective screening based on self-reported risk factors alone, as this approach misses >50% of women who give birth to infants with congenital toxoplasmosis. 2
  • In HIV-infected children, do not exclude toxoplasmic encephalitis based on negative serology alone—cases have been reported without detectable IgG antibodies. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Toxoplasmosis Prevention and Transmission Risks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acquired Toxoplasmosis in Immunocompetent Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Clinical Presentations and Management of TORCH Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.